Abstract | INTRODUCTION:
Asthma is a chronic inflammatory disease that causes significant morbidity and mortality. Inhaled corticosteroids are the preferred initial treatment for this disorder. Mometasone furoate dry powder is an inhaled corticosteroid that is approved for once-daily treatment of asthma in both adults and children as young as 4 years. AREAS COVERED: EXPERT OPINION:
|
Authors | Tracy B Fausnight, Timothy J Craig |
Journal | Expert opinion on pharmacotherapy
(Expert Opin Pharmacother)
Vol. 12
Issue 17
Pg. 2707-12
(Dec 2011)
ISSN: 1744-7666 [Electronic] England |
PMID | 22049912
(Publication Type: Journal Article, Review)
|
Chemical References |
- Anti-Inflammatory Agents
- Pregnadienediols
- Mometasone Furoate
|
Topics |
- Anti-Inflammatory Agents
(pharmacology, therapeutic use)
- Asthma
(drug therapy, metabolism)
- Dry Powder Inhalers
- Humans
- Mometasone Furoate
- Pregnadienediols
(pharmacology, therapeutic use)
- Quality of Life
|